XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 3,764,675 4,888,192 11,937,045 13,798,251
General and administrative 3,733,326 3,024,783 11,129,463 9,038,949
Stock-based compensation – general and administrative 1,174,111 1,003,677 3,540,787 2,929,279
Total Operating Expenses 8,672,112 8,916,652 26,607,295 25,766,479
Operating Loss (8,672,112) (8,916,652) (26,607,295) (25,766,479)
Other Income        
Interest income 336,780 53,020 854,604 116,573
Gain on sale of New Jersey net operating losses 3,585,689
Total Other Income 336,780 53,020 4,440,293 116,573
Loss before Income Taxes (8,335,332) (8,863,632) (22,167,002) (25,649,906)
Income tax expense 144,000 432,000
Net Loss $ (8,479,332) $ (8,863,632) $ (22,599,002) $ (25,649,906)
Net Loss Per Share - Basic (in Dollars per share) $ (0.06) $ (0.06) $ (0.15) $ (0.18)
Weighted Average Common Shares Outstanding        
Basic (in Shares) 153,775,380 146,129,630 148,746,002 146,061,108